首页|血清IFN-γ、IL-10、ADA对活动性肺结核的诊断价值及与治疗效果的相关性分析

血清IFN-γ、IL-10、ADA对活动性肺结核的诊断价值及与治疗效果的相关性分析

扫码查看
目的 探讨干扰素-γ(IFN-γ)、白细胞介素-10(IL-10)和腺苷脱氨酶(ADA)在活动性肺结核中的诊断价值,并分析IFN-γ、IL-10、ADA水平与其治疗效果的相关性,以期为临床治疗提供参考.方法 选取2020年6月—2022年7月在河北医科大学附属石家庄第五医院治疗的44例活动性肺结核患者作为活动组,40例非活动性肺结核患者作为非活动性肺结核组,另选取同期进行健康体检者38例为健康组.比较3组研究对象入组时IFN-γ、IL-10及ADA水平;分析IFN-γ、IL-10及ADA单独及联合检测(并联试验法)对活动性肺结核的诊断效能;统计活动性肺结核患者治疗6个月时的临床治疗效果;观察不同疗效患者治疗前、后6个月血清IFN-γ、IL-10及ADA水平变化,分析影响活动性肺结核患者治疗效果的相关因素.结果 活动组患者IFN-γ、IL-10及ADA水平均高于非活动组患者和健康组研究对象;非活动组患者IFN-γ、IL-10及ADA水平均高于健康组研究对象,差异均有统计学意义(P<0.05).IFN-γ、IL-10、ADA联合诊断活动性肺结核灵敏度、特异度、AUC(95%CI)分别为90.00%、89.00%、0.883(0.860~0.905),均高于IFN-γ、IL-10、ADA单独检测活动性肺结核的诊断效能.经治疗后,活动组患者有效36例、无效8例.2组患者病情严重程度分布比较,差异有统计学意义(P<0.05).治疗前,2组患者IFN-γ、IL-10及ADA水平比较,差异均无统计学意义(P>0.05).治疗后,2组患者IFN-γ、IL-10及ADA水平均低于治疗前,且有效组低于无效组,差异均有统计学意义(P<0.05).多元回归分析结果显示:病情程度、IFN-γ、IL-10、ADA水平均为影响活动性肺结核患者疗效的独立影响因素(P<0.05).结论 活动性肺结核患者中IFN-γ、IL-10、ADA水平升高,有望成为活动性肺结核的鉴别诊断指标,且与活动性肺结核疗效显著相关.因此,动态检测IFN-γ、IL-10、ADA水平对评估疗效有着较高参考价值.
Diagnostic value of serum IFN-γ,IL-10,and ADA in active tuberculosis and their correlation with treatment efficacy
Objective To explore the diagnostic effectiveness of serum interferon-γ(IFN-γ),interleukin-10(IL-10),and a-denosine deaminase(ADA)in active pulmonary tuberculosis and analyze the correlation between IFN-γ,IL-10,ADA levels and treatment efficacy,aiming to provide a reference for clinical treatment.Methods A total of 44 patients with active pul-monary tuberculosis treated at our hospital from June 2020 to July 2022 were selected as the active group,40 patients with non-active pulmonary tuberculosis as the non-active group,and 38 healthy individuals undergoing physical examinations dur-ing the same period as the healthy group.The levels of IFN-γ,IL-10,and ADA were compared among the three groups at baseline,and the diagnostic efficacy of IFN-γ,IL-10,and ADA alone and in combination(parallel test method)for active pulmonary tuberculosis was analyzed.The clinical treatment effects of patients with active pulmonary tuberculosis after 6 months of treatment were statistically analyzed.Furthermore,the changes in serum IFN-γ,IL-10,and ADA levels before and after 6 months of treatment in patients with different treatment outcomes were observed,and the factors affecting the treatment efficacy of patients with active pulmonary tuberculosis were also analyzed.Results The levels of IFN-γ,IL-10,and ADA in the active group were higher than those in the non-active group and the healthy group;the levels of IFN-γ,IL-10,and ADA in the non-active group were higher than those in the healthy group,with statistically significant differences(P<0.05).The sensitivity,specificity,and AUC(95%CI)of combined diagnosis of IFN-γ,IL-10,and ADA for active pulmonary tuberculosis were 90.00%,89.00%,and 0.883(0.860-0.905),respectively,which were higher than those of IFN-γ,IL-10,and ADA alone in diagnosing active pulmonary tuberculosis.After treatment,36 patients in the active group were effective and 8 were ineffective.A statistically significant difference was noted in the distribution of disease severity be-tween the two groups(P<0.05).Before treatment,no statistically significant difference was noted in the levels of IFN-γ,IL-10,and ADA between the two groups(P>0.05).After treatment,the levels of IFN-γ,IL-10,and ADA in both groups showed a decline,and the effective group was lower than the ineffective group,with statistically significant differ-ences(P<0.05).The results of multiple regression analysis showed disease severity and levels of IFN-γ,IL-10,and ADA were independent influencing factors for the treatment efficacy of patients with active pulmonary tuberculosis(P<0.05).Conclusion The levels of IFN-γ,IL-10,and ADA are elevated in patients with active pulmonary tuberculosis and can serve as potential differential diagnostic indicators for active pulmonary tuberculosis,and are significantly correlated with the treat-ment efficacy of active pulmonary tuberculosis.Therefore,dynamic detection of IFN-γ,IL-10,and ADA levels has a high reference value for evaluating treatment efficacy.

IFN-γIL-10ADAActive tuberculosisDiagnosisEfficacy evaluation

苏圆圆、戎燕筱、王海宾、王慰、孙雪培、王倩、张坤坤

展开 >

河北医科大学附属石家庄第五医院结核一科,石家庄 050021

IFN-γ IL-10 ADA 活动性肺结核 诊断 疗效评估

2024

保健医学研究与实践
西南大学

保健医学研究与实践

CSTPCD
影响因子:0.512
ISSN:1673-873X
年,卷(期):2024.21(10)